Anti-CD22 [hL22 (Epratuzumab)], Clone: [hL22 Epratuzumab], Unconjugated, Human, Monoclonal
Artikelnummer:
BYT-ORB411594
Produktübersicht
Artikelname:
Anti-CD22 [hL22 (Epratuzumab)], Clone: [hL22 Epratuzumab], Unconjugated, Human, Monoclonal
Artikelnummer:
BYT-ORB411594
Hersteller Artikelnummer:
orb411594
Alternativnummer:
BYT-ORB411594-0.2
Hersteller:
Biorbyt
Wirt:
Human
Kategorie:
Antikörper
Applikation:
Blocking, FC, IP
Spezies Reaktivität:
Human, Primate
Immunogen:
This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010).
Konjugation:
Unconjugated
Alternative Synonym:
Leu14, B-cell receptor CD22, B-lymphocyte cell adhesion molecule, BL-CAM, Sialic acid-binding Ig-like lectin 2, Siglec-2, T-cell surface antigen Leu-14
Produktbeschreibung
Human monoclonal antibody to CD22
Produkteigenschaften
Klonalität:
Monoclonal
Konzentration:
1 mg/ml
Klon-Bezeichnung:
[hL22 Epratuzumab]
UniProt:
P20273
Puffer:
PBS with 0.02% Proclin 300.
Reinheit:
Purified
Target-Kategorie:
CD22
